Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucin-1 | 15 | 2023 | 529 | 2.870 |
Why?
|
Vimentin | 3 | 2018 | 273 | 1.200 |
Why?
|
Breast Neoplasms | 29 | 2021 | 20066 | 0.810 |
Why?
|
Carcinoma, Ductal, Breast | 6 | 2018 | 1106 | 0.730 |
Why?
|
Receptor, erbB-2 | 12 | 2021 | 2309 | 0.630 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 6 | 2014 | 339 | 0.590 |
Why?
|
Neoplastic Stem Cells | 8 | 2022 | 1371 | 0.560 |
Why?
|
Interferon-gamma | 2 | 2022 | 3248 | 0.550 |
Why?
|
Cadherins | 2 | 2018 | 912 | 0.490 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2022 | 8560 | 0.440 |
Why?
|
Neuroendocrine Cells | 2 | 2022 | 63 | 0.420 |
Why?
|
BRCA1 Protein | 2 | 2015 | 1042 | 0.420 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 4 | 2016 | 175 | 0.400 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2022 | 607 | 0.390 |
Why?
|
Transcription Factors | 8 | 2023 | 11942 | 0.380 |
Why?
|
Receptors, Progesterone | 9 | 2015 | 1119 | 0.370 |
Why?
|
Receptors, Estrogen | 9 | 2015 | 2172 | 0.340 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9494 | 0.330 |
Why?
|
Antigens, CD | 1 | 2018 | 4149 | 0.300 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2020 | 311 | 0.300 |
Why?
|
Cell Line, Tumor | 12 | 2023 | 16726 | 0.300 |
Why?
|
Immunohistochemistry | 12 | 2021 | 11664 | 0.290 |
Why?
|
Loss of Heterozygosity | 3 | 2015 | 675 | 0.290 |
Why?
|
Leukemia, Myeloid | 2 | 2005 | 726 | 0.280 |
Why?
|
GATA3 Transcription Factor | 2 | 2016 | 162 | 0.260 |
Why?
|
Colorectal Neoplasms | 6 | 2023 | 6588 | 0.260 |
Why?
|
Lymphatic Metastasis | 7 | 2018 | 2967 | 0.250 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2017 | 8897 | 0.250 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3423 | 0.240 |
Why?
|
DNA Methylation | 2 | 2015 | 4070 | 0.210 |
Why?
|
Prognosis | 20 | 2020 | 28991 | 0.210 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3050 | 0.210 |
Why?
|
Aromatase Inhibitors | 3 | 2016 | 502 | 0.210 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2017 | 623 | 0.210 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2021 | 71 | 0.200 |
Why?
|
Kaplan-Meier Estimate | 6 | 2018 | 6727 | 0.200 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 1937 | 0.190 |
Why?
|
STAT1 Transcription Factor | 1 | 2021 | 320 | 0.180 |
Why?
|
Interferons | 1 | 2023 | 677 | 0.180 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3738 | 0.180 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 106 | 0.180 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2021 | 731 | 0.180 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 4 | 2014 | 51 | 0.170 |
Why?
|
Neoplasm Invasiveness | 4 | 2017 | 3681 | 0.170 |
Why?
|
Tamoxifen | 2 | 2013 | 992 | 0.170 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2022 | 274 | 0.170 |
Why?
|
Exosomes | 1 | 2023 | 402 | 0.170 |
Why?
|
Leukemia | 3 | 2014 | 1514 | 0.170 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2022 | 353 | 0.170 |
Why?
|
Humans | 63 | 2023 | 715594 | 0.160 |
Why?
|
Wound Closure Techniques | 1 | 2018 | 82 | 0.160 |
Why?
|
Spores, Bacterial | 1 | 2017 | 129 | 0.150 |
Why?
|
Pneumonectomy | 2 | 2017 | 1076 | 0.150 |
Why?
|
DNA-Binding Proteins | 6 | 2023 | 9730 | 0.150 |
Why?
|
Japan | 6 | 2020 | 1336 | 0.150 |
Why?
|
Metaplasia | 1 | 2017 | 310 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2020 | 11238 | 0.150 |
Why?
|
Esophageal Neoplasms | 3 | 2019 | 1509 | 0.150 |
Why?
|
Phyllodes Tumor | 1 | 2016 | 54 | 0.150 |
Why?
|
Axilla | 1 | 2018 | 540 | 0.140 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2016 | 313 | 0.140 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2296 | 0.140 |
Why?
|
Microsatellite Instability | 2 | 2016 | 661 | 0.140 |
Why?
|
Stomach Neoplasms | 3 | 2019 | 1243 | 0.140 |
Why?
|
Female | 41 | 2022 | 377052 | 0.140 |
Why?
|
Menstrual Cycle | 1 | 2018 | 533 | 0.140 |
Why?
|
Retroviridae | 3 | 2007 | 954 | 0.130 |
Why?
|
Cytidine Deaminase | 1 | 2016 | 237 | 0.130 |
Why?
|
Chromatin | 2 | 2023 | 2678 | 0.130 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2014 | 47 | 0.130 |
Why?
|
Prostatic Neoplasms | 4 | 2021 | 10595 | 0.130 |
Why?
|
Bacillus subtilis | 1 | 2017 | 361 | 0.130 |
Why?
|
Digestive System Surgical Procedures | 1 | 2019 | 565 | 0.130 |
Why?
|
Multiprotein Complexes | 1 | 2020 | 1156 | 0.120 |
Why?
|
Neoplasm Staging | 8 | 2017 | 11139 | 0.120 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 408 | 0.120 |
Why?
|
Middle Aged | 29 | 2020 | 214639 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1629 | 0.120 |
Why?
|
Carbon Dioxide | 1 | 2017 | 1130 | 0.120 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2013 | 128 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 844 | 0.120 |
Why?
|
Esophagectomy | 2 | 2014 | 459 | 0.120 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 1234 | 0.120 |
Why?
|
DNA Damage | 1 | 2023 | 2429 | 0.110 |
Why?
|
Immune System | 1 | 2018 | 797 | 0.110 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2012 | 98 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 3 | 2010 | 3387 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2015 | 0.110 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5995 | 0.110 |
Why?
|
Enhancer Elements, Genetic | 2 | 2010 | 1356 | 0.110 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1482 | 0.110 |
Why?
|
Adenocarcinoma | 2 | 2022 | 6320 | 0.110 |
Why?
|
Lymph Node Excision | 1 | 2018 | 1192 | 0.110 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 154 | 0.110 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2012 | 99 | 0.110 |
Why?
|
Signal Transduction | 8 | 2023 | 23705 | 0.110 |
Why?
|
Laryngectomy | 1 | 2014 | 234 | 0.110 |
Why?
|
Fanconi Anemia | 1 | 2014 | 319 | 0.110 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2012 | 151 | 0.110 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 985 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 712 | 0.100 |
Why?
|
Lung Neoplasms | 3 | 2022 | 12530 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2022 | 1510 | 0.100 |
Why?
|
Pharynx | 1 | 2014 | 417 | 0.100 |
Why?
|
Neuronal Plasticity | 1 | 2020 | 1405 | 0.100 |
Why?
|
Disease-Free Survival | 7 | 2016 | 7015 | 0.100 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2822 | 0.100 |
Why?
|
Hemangioblasts | 1 | 2010 | 29 | 0.100 |
Why?
|
Femur Neck | 1 | 2012 | 307 | 0.100 |
Why?
|
RNA, Messenger | 2 | 2016 | 13203 | 0.100 |
Why?
|
Ganglia, Spinal | 2 | 2003 | 506 | 0.100 |
Why?
|
Proportional Hazards Models | 5 | 2016 | 12495 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2129 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 3991 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1011 | 0.090 |
Why?
|
Head and Neck Neoplasms | 2 | 2014 | 2718 | 0.090 |
Why?
|
Glutamine | 1 | 2012 | 556 | 0.090 |
Why?
|
RNA-Binding Proteins | 2 | 2016 | 1883 | 0.090 |
Why?
|
Cell Adhesion Molecules | 2 | 2013 | 1638 | 0.090 |
Why?
|
Premenopause | 1 | 2013 | 1023 | 0.090 |
Why?
|
Mastectomy | 1 | 2017 | 1703 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4635 | 0.090 |
Why?
|
Nuclear Proteins | 3 | 2020 | 5933 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2014 | 792 | 0.090 |
Why?
|
Hernia | 1 | 2008 | 66 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 1994 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 648 | 0.080 |
Why?
|
Sciatic Neuropathy | 1 | 2008 | 74 | 0.080 |
Why?
|
Ki-67 Antigen | 3 | 2015 | 628 | 0.080 |
Why?
|
Reconstructive Surgical Procedures | 3 | 2019 | 2115 | 0.080 |
Why?
|
Echinococcus granulosus | 1 | 2007 | 8 | 0.080 |
Why?
|
Echinococcosis, Hepatic | 1 | 2007 | 20 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4887 | 0.080 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2013 | 1191 | 0.080 |
Why?
|
Leukemia, Experimental | 1 | 2007 | 258 | 0.080 |
Why?
|
Receptors, Androgen | 1 | 2013 | 1047 | 0.080 |
Why?
|
Fluorouracil | 1 | 2012 | 1609 | 0.080 |
Why?
|
Terminal Repeat Sequences | 1 | 2007 | 76 | 0.080 |
Why?
|
Adult | 15 | 2020 | 212237 | 0.080 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2013 | 871 | 0.080 |
Why?
|
Aged | 15 | 2020 | 162392 | 0.080 |
Why?
|
Retroviridae Infections | 1 | 2007 | 160 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3357 | 0.070 |
Why?
|
Mutation | 4 | 2023 | 29253 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3424 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2009 | 2983 | 0.070 |
Why?
|
Carcinoma | 1 | 2017 | 2319 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7445 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2012 | 1835 | 0.070 |
Why?
|
Colony-Forming Units Assay | 1 | 2005 | 368 | 0.070 |
Why?
|
Gene Dosage | 2 | 2012 | 1268 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2013 | 6092 | 0.070 |
Why?
|
Intestinal Obstruction | 1 | 2008 | 421 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 4978 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2031 | 0.060 |
Why?
|
Pleural Neoplasms | 1 | 2009 | 618 | 0.060 |
Why?
|
Genes, ras | 1 | 2007 | 706 | 0.060 |
Why?
|
Axons | 2 | 2003 | 1728 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2020 | 58293 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 4907 | 0.060 |
Why?
|
Osteosarcoma | 1 | 2009 | 891 | 0.060 |
Why?
|
Emigration and Immigration | 1 | 2007 | 382 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2922 | 0.060 |
Why?
|
Tumor Virus Infections | 1 | 2007 | 455 | 0.060 |
Why?
|
Mice, Nude | 2 | 2022 | 3800 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5319 | 0.060 |
Why?
|
Receptor, trkC | 1 | 2003 | 69 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2937 | 0.060 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2023 | 87 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13219 | 0.060 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 660 | 0.060 |
Why?
|
Ligands | 2 | 2023 | 3286 | 0.060 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1907 | 0.060 |
Why?
|
Mice | 13 | 2020 | 80270 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2020 | 4263 | 0.060 |
Why?
|
Inflammation | 1 | 2022 | 10090 | 0.060 |
Why?
|
Animals | 17 | 2022 | 169173 | 0.060 |
Why?
|
HCT116 Cells | 2 | 2014 | 407 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 20515 | 0.060 |
Why?
|
Sequence Deletion | 1 | 2007 | 1548 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6274 | 0.050 |
Why?
|
Receptors, Interferon | 1 | 2022 | 119 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11644 | 0.050 |
Why?
|
Proprioception | 1 | 2002 | 125 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2005 | 785 | 0.050 |
Why?
|
Treatment Outcome | 10 | 2019 | 62039 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2971 | 0.050 |
Why?
|
Down-Regulation | 2 | 2019 | 3070 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 2 | 2017 | 1156 | 0.050 |
Why?
|
POU Domain Factors | 1 | 2020 | 40 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2014 | 3551 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39334 | 0.050 |
Why?
|
Synaptophysin | 1 | 2020 | 140 | 0.050 |
Why?
|
Neurons, Afferent | 1 | 2002 | 511 | 0.050 |
Why?
|
Point Mutation | 1 | 2005 | 1647 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2020 | 8888 | 0.050 |
Why?
|
Bone Density | 1 | 2012 | 3415 | 0.050 |
Why?
|
Gastric Mucosa | 1 | 2002 | 596 | 0.040 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2020 | 238 | 0.040 |
Why?
|
Haplotypes | 1 | 2005 | 2883 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2020 | 290 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2014 | 22636 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2022 | 756 | 0.040 |
Why?
|
Hydrostatic Pressure | 1 | 2017 | 108 | 0.040 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 469 | 0.040 |
Why?
|
Epithelium | 1 | 2002 | 1720 | 0.040 |
Why?
|
Asia | 1 | 2018 | 641 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 373 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 525 | 0.040 |
Why?
|
Male | 14 | 2022 | 350143 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 422 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2020 | 10600 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 1395 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 515 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2020 | 72448 | 0.040 |
Why?
|
Oncogenes | 1 | 2022 | 1246 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2020 | 1691 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20337 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6476 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2005 | 3525 | 0.030 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2528 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 578 | 0.030 |
Why?
|
DNA Helicases | 1 | 2020 | 824 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2644 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 735 | 0.030 |
Why?
|
Dogs | 1 | 2019 | 4043 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1779 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4692 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2020 | 986 | 0.030 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 2932 | 0.030 |
Why?
|
Immunomagnetic Separation | 1 | 2013 | 84 | 0.030 |
Why?
|
Base Sequence | 3 | 2011 | 13171 | 0.030 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2014 | 148 | 0.030 |
Why?
|
Endothelium | 1 | 2016 | 801 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2168 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1136 | 0.030 |
Why?
|
Taxoids | 1 | 2017 | 653 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2018 | 671 | 0.030 |
Why?
|
Cleidocranial Dysplasia | 1 | 2012 | 18 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1205 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2018 | 951 | 0.030 |
Why?
|
Postoperative Care | 1 | 2019 | 1510 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2014 | 17399 | 0.030 |
Why?
|
Color | 1 | 2013 | 308 | 0.030 |
Why?
|
Cell Survival | 2 | 2016 | 6028 | 0.030 |
Why?
|
Drainage | 1 | 2018 | 1132 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2011 | 18583 | 0.030 |
Why?
|
Hot Temperature | 1 | 2017 | 1322 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 16559 | 0.030 |
Why?
|
Prostate | 1 | 2020 | 1593 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2016 | 752 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2879 | 0.030 |
Why?
|
Remission Induction | 1 | 2017 | 2392 | 0.030 |
Why?
|
Gene Deletion | 2 | 2014 | 2820 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2014 | 15101 | 0.030 |
Why?
|
Femoral Neck Fractures | 1 | 2012 | 141 | 0.030 |
Why?
|
Phenobarbital | 1 | 2011 | 186 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2010 | 9838 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2015 | 1090 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2013 | 333 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 690 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15185 | 0.020 |
Why?
|
Mice, Mutant Strains | 2 | 2005 | 1932 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2014 | 949 | 0.020 |
Why?
|
Mice, Knockout | 4 | 2009 | 15040 | 0.020 |
Why?
|
Carcinoma, Medullary | 1 | 2010 | 124 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2443 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2033 | 0.020 |
Why?
|
Receptors, Calcitriol | 1 | 2012 | 351 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3124 | 0.020 |
Why?
|
Chondroblastoma | 1 | 2009 | 51 | 0.020 |
Why?
|
Breast | 1 | 2018 | 1819 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2005 | 18175 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1910 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40889 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21804 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 1891 | 0.020 |
Why?
|
Thoracoscopy | 1 | 2009 | 181 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9555 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2017 | 2990 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 1044 | 0.020 |
Why?
|
Medical Oncology | 1 | 2020 | 2121 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 56140 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3670 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3211 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2094 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2011 | 12490 | 0.020 |
Why?
|
Hypertonic Solutions | 1 | 2007 | 94 | 0.020 |
Why?
|
Image Enhancement | 1 | 2018 | 2977 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 2011 | 702 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2012 | 1307 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2016 | 2515 | 0.020 |
Why?
|
Radiotherapy | 1 | 2014 | 1613 | 0.020 |
Why?
|
Ultrasonography | 2 | 2012 | 5921 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4303 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3800 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5407 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2009 | 492 | 0.020 |
Why?
|
Ascites | 1 | 2008 | 341 | 0.020 |
Why?
|
Stroke Volume | 1 | 2019 | 4482 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 5045 | 0.020 |
Why?
|
Carcinoma, Lobular | 1 | 2010 | 495 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1985 | 0.020 |
Why?
|
Punctures | 1 | 2007 | 366 | 0.020 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 198 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2551 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2016 | 2555 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3543 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5275 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13619 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2095 | 0.020 |
Why?
|
Integrin beta3 | 1 | 2005 | 119 | 0.020 |
Why?
|
Rare Diseases | 1 | 2009 | 529 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.020 |
Why?
|
Length of Stay | 1 | 2018 | 6272 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2005 | 299 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9810 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2009 | 1673 | 0.020 |
Why?
|
Peru | 1 | 2007 | 845 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1833 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6732 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4104 | 0.020 |
Why?
|
Transfection | 1 | 2012 | 6081 | 0.020 |
Why?
|
Neurons | 1 | 2003 | 9371 | 0.010 |
Why?
|
Patient Compliance | 1 | 2013 | 2745 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2009 | 1343 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 12285 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 5069 | 0.010 |
Why?
|
Motor Skills Disorders | 1 | 2002 | 88 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2002 | 371 | 0.010 |
Why?
|
Biopsy, Fine-Needle | 1 | 2007 | 1059 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2003 | 610 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 2777 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2005 | 752 | 0.010 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 657 | 0.010 |
Why?
|
Ataxia | 1 | 2003 | 285 | 0.010 |
Why?
|
Ethanol | 1 | 2007 | 1252 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12547 | 0.010 |
Why?
|
Risk Factors | 2 | 2017 | 70931 | 0.010 |
Why?
|
Insulin | 1 | 2014 | 6654 | 0.010 |
Why?
|
Hyperplasia | 1 | 2002 | 1166 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2003 | 1602 | 0.010 |
Why?
|
Apoptosis | 2 | 2007 | 9960 | 0.010 |
Why?
|
Gene Targeting | 1 | 2002 | 902 | 0.010 |
Why?
|
Posture | 1 | 2003 | 986 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10513 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16302 | 0.010 |
Why?
|
Stomach | 1 | 2002 | 667 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3480 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7877 | 0.010 |
Why?
|
Radiography | 1 | 2008 | 6976 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15606 | 0.010 |
Why?
|
Leukocytes | 1 | 2005 | 2092 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5190 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2002 | 2839 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10285 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 1745 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9544 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2463 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 13209 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 12268 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 8028 | 0.010 |
Why?
|
Aging | 1 | 2013 | 8352 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3959 | 0.010 |
Why?
|
Spinal Cord | 1 | 2003 | 1807 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 51354 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2002 | 1973 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20761 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 34429 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 11098 | 0.010 |
Why?
|
Child | 1 | 2016 | 74413 | 0.010 |
Why?
|
Risk Assessment | 1 | 2009 | 23482 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 85064 | 0.010 |
Why?
|
Rats | 1 | 2002 | 24794 | 0.000 |
Why?
|